Market Dynamics
Global Psoriasis Treatment Market Outlook for the period 2018-2032 is to include advancements in the medical industry with regards to treatments for psoriasis. Effective treatments are available that can provide relief symptoms of psoriasis such as inflammation and itching, reduce plaque thickness, and reduce the severity of flare-ups. Biologic therapies, topical therapies, and phototherapy are the most common treatment options for Psoriasis. Biologic therapies have proven to be the most efficient and advanced treatment strategies for psoriasis in terms of long-term efficacy. At present, biologic therapies are being delivered via a subcutaneous injection and this delivery system is expected to continue through the forecasted period of 2018-2032. In the biologic therapy segment, notable market players in the Global Psoriasis Treatment Market are Abbott Laboratories, Amgen, AstraZeneca, Boehringer Ingelheim, Janssen Biotech, and Celgene. A notable trend within this segment is the development of biosimilars that are expected to increase competition and bring down the cost of treatment. As for topical therapies, standard treatments include steroids, retinoids, vitamin D analogs, and coal tar. Pharmaceuticals companies such as Galderma S.A., Mylan N.V., and Perrigo Company PLC are highlighted producers of corticosteroids used for psoriasis treatment.
Corticosteroids creams are cheaper than biologics and used as the first line of treatment for mild to moderate symptoms. Phototherapy has also become increasingly recognized as an effective psoriasis treatment option. Phototherapy involves the use of light sources such as ultraviolet A and B radiation, laser therapy, and photochemotherapy. Companies such as Philips, KUWAIT LIGHT and PHOTOTHERAPY EQUIPMENT LLC, Daavlin LLC, and BioLight Life Sciences Ltd are some of the key players within the market. To conclude, the Global Psoriasis Treatment Market Outlook for the period 2018-2032 is expected to see a demand in treatments that can provide efficient relief of symptoms associated with Psoriasis. An increase in the development of biosimilars and the emergence of technologically advanced treatments will bring in new opportunities within the market.
